Forecast: Antiretroviral Therapy Coverage in Middle East & North Africa

Antiretroviral therapy coverage in the Middle East & North Africa has shown a consistent upward trajectory. In 2023, the coverage stood at 52.44 units of persons living with HIV. Over the period from 2013 to 2022, the year-on-year variations have generally decreased from a high of 21.44% in 2015 to 4.89% in 2023. The CAGR for the last five years ending in 2023 was 5.81%, highlighting a slowing but steady rate of increase. For the forecast period from 2024 to 2028, the CAGR is anticipated to be 3.21%, with an overall growth rate of 17.13% over these five years.

Future trends to watch for include:

  • The impact of new policies and healthcare initiatives aimed at increasing therapy coverage
  • The availability of funding and resources for antiretroviral therapy programs
  • The potential influence of emerging medical technologies and treatments on coverage expansion
  • Socio-economic factors that may affect access and adherence to therapy

Top Countries about Antiviral